BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16709449)

  • 1. The program for phenotyping of genetically modified animals at AstraZeneca.
    Berg AL; Bohlooly-Y M
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):383-4. PubMed ID: 16709449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered mouse models in drug discovery research.
    Sacca R; Engle SJ; Qin W; Stock JL; McNeish JD
    Methods Mol Biol; 2010; 602():37-54. PubMed ID: 20012391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future approaches using genetically modified mice in endocrine research.
    Davey RA; MacLean HE
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E429-38. PubMed ID: 16684850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural phenotyping of transgenic mice.
    Brown RE
    Can J Exp Psychol; 2007 Dec; 61(4):328-44. PubMed ID: 18266509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of genetically modified mouse models for evaluation of carcinogenic risk: considerations for the laboratory animal scientist.
    Recio L; Everitt J
    Comp Med; 2001 Oct; 51(5):399-405. PubMed ID: 11924798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice.
    Crawley JN; Paylor R
    Horm Behav; 1997 Jun; 31(3):197-211. PubMed ID: 9213134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of genetically altered mouse models for aging studies.
    Treuting PM; Hopkins HC; Ware CA; Rabinovitch PR; Ladiges WC
    Exp Mol Pathol; 2002 Feb; 72(1):49-55. PubMed ID: 11784122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: Strategies for developing genetically modified mice.
    Hofker MH
    Methods Mol Biol; 2011; 693():1-10. PubMed ID: 21080271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of therapeutic drug targets through genetically manipulated mice: are we getting it right?
    Matthaei KI
    Pharmacol Ther; 2009 Jul; 123(1):32-6. PubMed ID: 19375454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
    Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular models of disease. Transgenes and knockout].
    Moradpour D
    Dtsch Med Wochenschr; 1997 Dec; 122(49):1527-30. PubMed ID: 9453919
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
    Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
    Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of phenotype in genetically engineered mice.
    Doetschman T
    Lab Anim Sci; 1999 Apr; 49(2):137-43. PubMed ID: 10331542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders.
    Takao K; Yamasaki N; Miyakawa T
    Neurosci Res; 2007 Jun; 58(2):124-32. PubMed ID: 17524507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
    Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
    Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions.
    Leiter EH
    Diabetologia; 2002 Mar; 45(3):296-308. PubMed ID: 11914735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearances can be deceiving: phenotypes of knockout mice.
    Barbaric I; Miller G; Dear TN
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):91-103. PubMed ID: 17584761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
    El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP
    Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.